{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T14:09:19Z","timestamp":1791641359690,"version":"4.3.4"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,5]],"date-time":"2023-08-05T00:00:00Z","timestamp":1691193600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017691","name":"Guangxi Key Research and Development Program","doi-asserted-by":"publisher","award":["AB20159024"],"award-info":[{"award-number":["AB20159024"]}],"id":[{"id":"10.13039\/501100017691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017691","name":"Guangxi Key Research and Development Program","doi-asserted-by":"publisher","award":["Z20190083"],"award-info":[{"award-number":["Z20190083"]}],"id":[{"id":"10.13039\/501100017691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.intimp.2023.110775","type":"journal-article","created":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T04:16:54Z","timestamp":1691468214000},"page":"110775","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Effect of X-ray irradiation combined with PD-1 inhibitor treatment on lung tissue injury in mice"],"prefix":"10.1016","volume":"123","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-1439-8234","authenticated-orcid":false,"given":"Leili","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2034-5722","authenticated-orcid":false,"given":"Weidong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cailan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shixiong","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.intimp.2023.110775_b0005","doi-asserted-by":"crossref","first-page":"5939","DOI":"10.1038\/s41598-021-85131-7","article-title":"A systematic review and meta-analysis of treatment-related toxicities of curative and palliative radiation therapy in non-small cell lung cancer","volume":"11","author":"Or","year":"2021","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.intimp.2023.110775_b0010","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.adro.2019.08.010","article-title":"Fatal radiation pneumonitis: literature review and case series","volume":"5","author":"Keffer","year":"2020","journal-title":"Adv. Radiat. Oncol."},{"key":"10.1016\/j.intimp.2023.110775_b0015","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1200\/JCO.2017.74.9846","article-title":"Safety and antitumor activity of the anti-programmed death-1 antibody pembrolizumab in patients with advanced esophageal carcinoma","volume":"36(1)","author":"Doi","year":"2018","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.intimp.2023.110775_b0020","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.trecan.2016.05.002","article-title":"Radiotherapy: changing the game in immunotherapy","volume":"2","author":"Demaria","year":"2016","journal-title":"Trends Cancer"},{"issue":"21","key":"10.1016\/j.intimp.2023.110775_b0025","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1200\/JCO.21.00174","article-title":"Five-year outcomes with pembrolizumab versus chemotherapy for metastatic non-small-cell lung cancer with PD-L1 tumor proportion score \u2265 50","volume":"39","author":"Reck","year":"2021","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.intimp.2023.110775_b0030","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1172\/JCI67313","article-title":"Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice","volume":"124","author":"Deng","year":"2014","journal-title":"J. Clin. Invest."},{"issue":"7547","key":"10.1016\/j.intimp.2023.110775_b0035","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nature14292","article-title":"Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer","volume":"520","author":"Twyman-Saint Victor","year":"2015","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.intimp.2023.110775_b0040","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.jtho.2017.04.014","article-title":"Combined radiotherapy and anti-PD-L1 antibody synergistically enhances antitumor effect in non-small cell lung cancer","volume":"12","author":"Gong","year":"2017","journal-title":"J. Thorac. Oncol."},{"issue":"24","key":"10.1016\/j.intimp.2023.110775_b0045","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1056\/NEJMoa1809697","article-title":"Overall survival with durvalumab after chemoradiotherapy in stage III NSCLC","volume":"379","author":"Antonia","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.intimp.2023.110775_b0050","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1001\/jamaoncol.2019.1478","article-title":"Effect of pembrolizumab after stereotactic body radiotherapy vs pembrolizumab alone on tumor response in patients with advanced non-small cell lung cancer: results of the PEMBRO-RT phase 2 randomized clinical trial","volume":"5","author":"Theelen","year":"2019","journal-title":"JAMA Oncol."},{"issue":"5","key":"10.1016\/j.intimp.2023.110775_b0055","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.jtho.2020.12.015","article-title":"Four-year survival with durvalumab after chemoradiotherapy in stage III NSCLC-an update from the PACIFIC trial","volume":"16","author":"Faivre-Finn","year":"2021","journal-title":"J. Thorac. Oncol."},{"issue":"8","key":"10.1016\/j.intimp.2023.110775_b0060","doi-asserted-by":"crossref","first-page":"e452","DOI":"10.1016\/S1470-2045(19)30171-8","article-title":"Optimising efficacy and reducing toxicity of anticancer radioimmunotherapy","volume":"20","author":"Deutsch","year":"2019","journal-title":"Lancet Oncol."},{"issue":"7","key":"10.1016\/j.intimp.2023.110775_b0065","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S1470-2045(17)30380-7","article-title":"Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: a secondary analysis of the KEYNOTE-001 phase 1 trial","volume":"18","author":"Shaverdian","year":"2017","journal-title":"Lancet Oncol."},{"issue":"4","key":"10.1016\/j.intimp.2023.110775_b0070","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1002\/cam4.3718","article-title":"Safety and Efficacy of PD-1\/PD-L1 inhibitors combined with radiotherapy in patients with non-small-cell lung cancer: a systematic review and meta-analysis","volume":"10","author":"Geng","year":"2021","journal-title":"Cancer Med."},{"key":"10.1016\/j.intimp.2023.110775_b0075","doi-asserted-by":"crossref","first-page":"545","DOI":"10.2147\/JIR.S350112","article-title":"Effect of PD-1 inhibitor combined with X-ray irradiation on the inflammatory microenvironment and lung tissue injury in mice","volume":"15","author":"Geng","year":"2022","journal-title":"J. Inflamm. Res."},{"issue":"3","key":"10.1016\/j.intimp.2023.110775_b0080","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1667\/RR15182.1","article-title":"Impact of radiotherapy concurrent with anti-PD-1 therapy on the lung tissue of tumor-bearing mice","volume":"191","author":"Wang","year":"2019","journal-title":"Radiat. Res."},{"issue":"8","key":"10.1016\/j.intimp.2023.110775_b0085","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19082460","article-title":"TGF-\u03b2 signaling in lung health and disease","volume":"19","author":"Saito","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.intimp.2023.110775_b0090","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1038\/ni.3558","article-title":"Regulation and function of the cGAS-STING pathway of cytosolic DNA sensing","volume":"17","author":"Chen","year":"2016","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2023.110775_b0095","doi-asserted-by":"crossref","first-page":"5226","DOI":"10.1038\/s41467-018-07425-1","article-title":"STING-dependent sensing of self-DNA drives silica-induced lung inflammation","volume":"9","author":"Benmerzoug","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2023.110775_b0100","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3389\/fimmu.2020.00615","article-title":"Research advances in how the cGAS-STING pathway controls the cellular inflammatory response","volume":"11","author":"Wan","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2023.110775_b0105","doi-asserted-by":"crossref","unstructured":"R. Mat\u011bj, D. Housa, P. Pouc\u0306kov\u00e1, M. Zadinov\u00e1, T. Olej\u00e1r, Radiation-induced production of PAR-1 and TGF-beta 1 mRNA in lung of C57Bl6 and C3H murine strains and influence of pharmacoprophylaxis by ACE inhibitors. Pathol. \u2013 Res. Pract. 203(2) (2007) 107\u2013114.","DOI":"10.1016\/j.prp.2006.10.006"},{"issue":"1","key":"10.1016\/j.intimp.2023.110775_b0110","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/HP.0b013e3182a32ccf","article-title":"Characterization of the dose response relationship for lung injury following acute radiation exposure in three well-established murine strains: developing an interspecies bridge to link animal models with human lung","volume":"106","author":"Jackson","year":"2014","journal-title":"Health Phys."},{"issue":"9","key":"10.1016\/j.intimp.2023.110775_b0115","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1038\/labinvest.2016.76","article-title":"A survey of changing trends in modelling radiation lung injury in mice: bringing out the good, the bad, and the uncertain","volume":"96","author":"Dabjan","year":"2016","journal-title":"Lab. Invest."},{"issue":"17","key":"10.1016\/j.intimp.2023.110775_b0120","doi-asserted-by":"crossref","first-page":"5379","DOI":"10.1158\/1078-0432.CCR-09-0265","article-title":"Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody","volume":"15","author":"Dewan","year":"2009","journal-title":"Clin. Cancer Res."},{"issue":"11","key":"10.1016\/j.intimp.2023.110775_b0125","doi-asserted-by":"crossref","first-page":"6254","DOI":"10.21037\/jtd.2018.10.01","article-title":"Evaluation of combined anti-PD-1 immunotherapy and radiation therapy in a preclinical mouse model of pneumonitis and fibrosis","volume":"10","author":"Nichols","year":"2018","journal-title":"J. Thorac. Dis."},{"issue":"4","key":"10.1016\/j.intimp.2023.110775_b0130","first-page":"425","article-title":"Gene expression profiles among murine strains segregate with distinct differences in the progression of radiation-induced lung disease","volume":"10","author":"Jackson","year":"2017","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.intimp.2023.110775_b0135","unstructured":"P. Ghafoori, L.B. Marks, Z. Vujaskovic, C.R. Kelsey, Radiation-induced lung injury. Assessment, management, and prevention. Oncology (Williston Park) 22(1) (2008) 37-47; discussion 52\u201333."},{"issue":"4","key":"10.1016\/j.intimp.2023.110775_b0140","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1034\/j.1399-3003.1999.13d05.x","article-title":"Bilateral lymphocytic alveolitis: a common reaction after unilateral thoracic irradiation","volume":"13","author":"Mart\u00edn","year":"1999","journal-title":"Eur. Respir. J."},{"issue":"4","key":"10.1016\/j.intimp.2023.110775_b0145","first-page":"250","article-title":"The bronchoalveolar lavage pattern in radiation pneumonitis secondary to radiotherapy for breast cancer","volume":"5","author":"Toma","year":"2010","journal-title":"Maedica (Bucur)"},{"key":"10.1016\/j.intimp.2023.110775_b0150","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1600-065X.2008.00616.x","article-title":"Multiple roles for CD4+ T cells in anti-tumor immune responses","volume":"222","author":"Kennedy","year":"2008","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.intimp.2023.110775_b0155","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.coi.2017.07.004","article-title":"Vaccines targeting helper T cells for cancer immunotherapy","volume":"47","author":"Melssen","year":"2017","journal-title":"Curr. Opin. Immunol."},{"issue":"8","key":"10.1016\/j.intimp.2023.110775_b0160","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/nri1413","article-title":"Helping the CD8(+) T-cell response","volume":"4","author":"Bevan","year":"2004","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2023.110775_b0165","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1146\/annurev.immunol.23.021704.115825","article-title":"Cooperation between CD4+ and CD8+ T cells: when, where, and how","volume":"24","author":"Castellino","year":"2006","journal-title":"Annu. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2023.110775_b0170","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/imr.12426","article-title":"CD4(+) T-cell help amplifies innate signals for primary CD8(+) T-cell immunity","volume":"272","author":"Bedoui","year":"2016","journal-title":"Immunol. Rev."},{"issue":"6","key":"10.1016\/j.intimp.2023.110775_b0175","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/j.cell.2015.08.004","article-title":"Robust anti-viral immunity requires multiple distinct T cell-dendritic cell interactions","volume":"162","author":"Eickhoff","year":"2015","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.intimp.2023.110775_b0180","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.immuni.2015.07.020","article-title":"Spatiotemporally distinct interactions with dendritic cell subsets facilitates CD4+ and CD8+ T cell activation to localized viral infection","volume":"43","author":"Hor","year":"2015","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.intimp.2023.110775_b0185","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1073\/pnas.1513607113","article-title":"Imaging of the cross-presenting dendritic cell subsets in the skin-draining lymph node","volume":"113","author":"Kitano","year":"2016","journal-title":"PNAS"},{"issue":"6","key":"10.1016\/j.intimp.2023.110775_b0190","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrneph.2016.48","article-title":"TGF-\u03b2: the master regulator of fibrosis","volume":"12","author":"Meng","year":"2016","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.intimp.2023.110775_b0195","doi-asserted-by":"crossref","first-page":"8319283","DOI":"10.1155\/2016\/8319283","article-title":"TGF-\u03b21\/Smads and miR-21 in renal fibrosis and inflammation","volume":"2016","author":"Loboda","year":"2016","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.intimp.2023.110775_b0200","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.biopha.2018.02.090","article-title":"Central role of dysregulation of TGF-\u03b2\/Smad in CKD progression and potential targets of its treatment","volume":"101","author":"Chen","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"4","key":"10.1016\/j.intimp.2023.110775_b0205","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/JTO.0b013e3181ce3afd","article-title":"TGF-beta signaling and the role of inhibitory Smads in non-small cell lung cancer","volume":"5","author":"Jeon","year":"2010","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.intimp.2023.110775_b0210","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3389\/fphar.2017.00461","article-title":"Targeting TGF-\u03b2 mediated SMAD signaling for the prevention of fibrosis","volume":"8","author":"Walton","year":"2017","journal-title":"Front. Pharmacol."},{"issue":"11","key":"10.1016\/j.intimp.2023.110775_b0215","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41576-019-0151-1","article-title":"DNA sensing by the cGAS-STING pathway in health and disease","volume":"20","author":"Motwani","year":"2019","journal-title":"Nat. Rev. Genet."},{"issue":"4","key":"10.1016\/j.intimp.2023.110775_b0220","doi-asserted-by":"crossref","first-page":"L569","DOI":"10.1152\/ajplung.00565.2016","article-title":"Activated human T lymphocytes inhibit TGF\u03b2-induced fibroblast to myofibroblast differentiation via prostaglandins D(2) and E(2)","volume":"314","author":"Lacy","year":"2018","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923011001?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923011001?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T14:36:15Z","timestamp":1736433375000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576923011001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":44,"alternative-id":["S1567576923011001"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110775","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of X-ray irradiation combined with PD-1 inhibitor treatment on lung tissue injury in mice","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110775","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"110775"}}